WEST PHARMACEUTICAL SERVICES INC【WST】Income statement

Market cap

$20B

P/E ratio

	2010/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	1,105	1,266	1,368	1,421	1,400	1,509	1,599	1,717	1,840	2,147	2,832	2,887	2,950	2,893
Revenue growth (%)	-	-
Cost of revenue	787	879	934	974	944	1,008	1,087	1,172	1,234	1,379	1,656	1,751	1,821	1,895
Gross profit	318	388	435	448	456	501	513	545	606	768	1,176	1,136	1,129	999
Gross margin (%)
Research & development	24	33	38	37	34	37	39	40	39	47	53	59	68	69
Selling, general & administrative	188	218	235	229	233	240	243	263	273	302	363	317	353	339
Operating margin (%)
Operating income	91	135	162	182	129	197	229	240	297	407	752	734	676	570
Income before tax	75	109	147	169	116	190	222	241	292	401	749	680	698	586
Pretax margin (%)	6.7	8.6	10.7	11.9	8.3	12.6	13.9	14	15.9	18.7	26.4	23.6	23.7	20.2
Provision for income taxes	14	33	40	47	26	54	81	41	59	73	107	115	122	108
Effective tax rate (%)
Net income	65	81	112	127	96	144	151	207	242	346	662	586	593	493
Net income margin (%)
Earnings per share	1.96	2.37	1.61	1.79	1.33	1.96	2.04	2.8	3.27	4.68	8.89	7.87	7.98	6.75
Diluted EPS	1.89	2.3	1.57	1.75	1.3	1.91	1.99	2.74	3.21	4.57	8.67	7.73	7.88	6.69
Dividend payout ratio (%)
Dividend per share	0.66	0.74	0.39	0.41	0.46	0.5	0.54	0.58	0.62	0.66	0.7	0.74	0.78	0.82